[go: up one dir, main page]

NO883959L - Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.

Info

Publication number
NO883959L
NO883959L NO88883959A NO883959A NO883959L NO 883959 L NO883959 L NO 883959L NO 88883959 A NO88883959 A NO 88883959A NO 883959 A NO883959 A NO 883959A NO 883959 L NO883959 L NO 883959L
Authority
NO
Norway
Prior art keywords
phenolesters
procedure
preparation
therapeutic active
therapeutic
Prior art date
Application number
NO88883959A
Other languages
English (en)
Other versions
NO883959D0 (no
Inventor
Geraint Jones
David Christopher Taylor
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721005A external-priority patent/GB8721005D0/en
Priority claimed from GB878729796A external-priority patent/GB8729796D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO883959D0 publication Critical patent/NO883959D0/no
Publication of NO883959L publication Critical patent/NO883959L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO88883959A 1987-09-07 1988-09-06 Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. NO883959L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721005A GB8721005D0 (en) 1987-09-07 1987-09-07 Phenol esters
GB878729796A GB8729796D0 (en) 1987-12-22 1987-12-22 Phenol esters

Publications (2)

Publication Number Publication Date
NO883959D0 NO883959D0 (no) 1988-09-06
NO883959L true NO883959L (no) 1989-03-08

Family

ID=26292700

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883959A NO883959L (no) 1987-09-07 1988-09-06 Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.

Country Status (10)

Country Link
EP (1) EP0307115A1 (no)
JP (1) JPH01121282A (no)
KR (1) KR890005077A (no)
AU (1) AU2061588A (no)
DK (1) DK472888A (no)
FI (1) FI883968A7 (no)
GB (1) GB8820277D0 (no)
HU (1) HUT48608A (no)
IL (1) IL87446A0 (no)
NO (1) NO883959L (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2263267C (en) * 1996-09-18 2006-05-02 Daiso Co., Ltd. Process for the preparation of glycidyl ethers
CA2263268C (en) * 1996-09-18 2005-11-01 Daiso Co., Ltd. Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
CN106456649A (zh) * 2014-02-18 2017-02-22 莱兰斯坦福初级大学评议会 用于改善具有神经障碍的人的认知和社交行为的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
ZA827646B (en) * 1981-11-12 1983-08-31 American Hospital Supply Corp Esters of aryloxypropanolamine derivatives
EP0085286B1 (en) * 1981-12-17 1986-04-30 Aktiebolaget Hässle Para-substituted 3-phenoxy-1-carbonylaminoalkylamino-propan-2-ols having beta receptor blocking properties
DE3428525A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von alkylendiamin-derivaten zur behandlung von durchblutungsstoerungen sowie arzneimittel, die diese verbindung enthalten

Also Published As

Publication number Publication date
KR890005077A (ko) 1989-05-11
FI883968L (fi) 1989-03-08
AU2061588A (en) 1989-03-09
EP0307115A1 (en) 1989-03-15
DK472888D0 (da) 1988-08-24
NO883959D0 (no) 1988-09-06
DK472888A (da) 1989-03-08
HUT48608A (en) 1989-06-28
FI883968A0 (fi) 1988-08-26
IL87446A0 (en) 1989-01-31
JPH01121282A (ja) 1989-05-12
GB8820277D0 (en) 1988-09-28
FI883968A7 (fi) 1989-03-08

Similar Documents

Publication Publication Date Title
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO884473L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.